-
1
-
-
0035894174
-
The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts
-
DOI 10.1016/S0006-2952(01)00806-1, PII S0006295201008061
-
M. Stiborová, C.A. Bieler, M. Wiessler, and E. Frei The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts Biochem Pharmacol 62 2001 1675 1684 (Pubitemid 34033654)
-
(2001)
Biochemical Pharmacology
, vol.62
, Issue.12
, pp. 1675-1684
-
-
Stiborova, M.1
Bieler, C.A.2
Wiessler, M.3
Frei, E.4
-
3
-
-
78649447922
-
Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency
-
M. Stiborová, M. Rupertová, and E. Frei Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency Biochim Biophys Acta 1814 2011 175 185
-
(2011)
Biochim Biophys Acta
, vol.1814
, pp. 175-185
-
-
Stiborová, M.1
Rupertová, M.2
Frei, E.3
-
4
-
-
0023617219
-
Multimodal action of antitumor agents on DNA: The ellipticine series
-
DOI 10.1016/0003-9861(87)90463-2
-
C. Auclair Multimodal action of antitumor agents on DNA: the ellipticine series Arch Biochem Biophys 259 1987 1 14 (Pubitemid 17164718)
-
(1987)
Archives of Biochemistry and Biophysics
, vol.259
, Issue.1
, pp. 1-14
-
-
Auclair, C.1
-
6
-
-
0027104314
-
Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: Structure-activity relationship
-
P. Fossé, B. René, M. Charra, C. Paoletti, and J.M. Saucier Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationships Mol Pharmacol 42 1992 590 595 (Pubitemid 23027620)
-
(1992)
Molecular Pharmacology
, vol.42
, Issue.4
, pp. 590-595
-
-
Fosse, P.1
Rene, B.2
Charra, M.3
Paoletti, C.4
Saucier, J.-M.5
-
7
-
-
0029015354
-
Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy
-
S.J. Froelich-Ammon, M.W. Patchan, N. Osheroff, and R.B. Thompson Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy J Biol Chem 270 1995 14998 15004
-
(1995)
J Biol Chem
, vol.270
, pp. 14998-15004
-
-
Froelich-Ammon, S.J.1
Patchan, M.W.2
Osheroff, N.3
Thompson, R.B.4
-
9
-
-
12244292673
-
Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans
-
DOI 10.1021/tx0200818
-
M. Stiborová, M. Stiborová-Rupertová, L. Bořek-Dohalská, M. Wiessler, and E. Frei Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans Chem Res Toxicol 16 2003 38 47 (Pubitemid 36139409)
-
(2003)
Chemical Research in Toxicology
, vol.16
, Issue.1
, pp. 38-47
-
-
Stiborova, M.1
Stiborova-Rupertova, M.2
Borek-Dohalska, L.3
Wiessler, M.4
Frei, E.5
-
10
-
-
8644288137
-
2-oxide
-
DOI 10.1158/0008-5472.CAN-04-2202
-
2-oxide Cancer Res 64 2004 8374 8380 (Pubitemid 39496831)
-
(2004)
Cancer Research
, vol.64
, Issue.22
, pp. 8374-8380
-
-
Stiborova, M.1
Sejbal, J.2
Borek-Dohalska, L.3
Aimova, D.4
Poljakova, J.5
Forsterova, K.6
Rupertova, M.7
Wiesner, J.8
Hudecek, J.9
Wiessler, M.10
Frei, E.11
-
11
-
-
33845624680
-
Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine
-
DOI 10.1002/ijc.22247
-
M. Stiborová, J. Poljaková, H. Ryšlavá, M. Dračínský, T. Eckschlager, and E. Frei Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine Int J Cancer 120 2007 243 251 (Pubitemid 44956832)
-
(2007)
International Journal of Cancer
, vol.120
, Issue.2
, pp. 243-251
-
-
Stiborova, M.1
Poljakova, J.2
Ryslava, H.3
Dracinsky, M.4
Eckschlager, T.5
Frei, E.6
-
12
-
-
34248652696
-
Formation and persistence of DNA adducts of anticancer drug ellipticine in rats
-
DOI 10.1016/j.tox.2007.03.026, PII S0300483X07002065
-
M. Stiborová, M. Rupertová, D. Aimová, H. Ryšlavá, and E. Frei Formation and persistence of DNA adducts of anticancer drug ellipticine in rats Toxicology 236 2007 50 60 (Pubitemid 46777068)
-
(2007)
Toxicology
, vol.236
, Issue.1-2
, pp. 50-60
-
-
Stiborova, M.1
Rupertova, M.2
Aimova, D.3
Ryslava, H.4
Frei, E.5
-
13
-
-
38649108546
-
Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: Studies with the hepatic NADPH:Cytochrome P450 reductase null mouse
-
DOI 10.1016/j.taap.2007.09.017, PII S0041008X07004231
-
M. Stiborová, V.M. Arlt, C.J. Henderson, C.R. Wolf, V. Kotrbová, and M. Moserová Role of hepatic cytochromes P450 in bioactivation of the anticancer drug ellipticine: studies with the hepatic NADPH:cytochrome P450 reductase null mouse Toxicol Appl Pharmacol 226 2008 318 327 (Pubitemid 351172414)
-
(2008)
Toxicology and Applied Pharmacology
, vol.226
, Issue.3
, pp. 318-327
-
-
Stiborova, M.1
Arlt, V.M.2
Henderson, C.J.3
Wolf, C.R.4
Kotrbova, V.5
Moserova, M.6
Hudecek, J.7
Phillips, D.H.8
Frei, E.9
-
14
-
-
1942422695
-
DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells
-
DOI 10.1135/cccc20040603
-
L. Bořek-Dohalská, E. Frei, and M. Stiborová DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells Collect Czech Chem Commun 69 2004 603 615 (Pubitemid 38526511)
-
(2004)
Collection of Czechoslovak Chemical Communications
, vol.69
, Issue.3
, pp. 603-615
-
-
Borek-Dohalska, L.1
Frei, E.2
Stiborova, M.3
-
15
-
-
34248662505
-
DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells
-
DOI 10.1016/j.canlet.2006.12.037, PII S0304383507000043
-
J. Poljaková, E. Frei, J.E. Gomez, D. Aimová, T. Eckschlager, and J. Hraběta DNA adduct formation by the anticancer drug ellipticine in human leukemia HL-60 and CCRF-CEM cells Cancer Lett 252 2007 270 279 (Pubitemid 46809792)
-
(2007)
Cancer Letters
, vol.252
, Issue.2
, pp. 270-279
-
-
Poljakova, J.1
Frei, E.2
Gomez, J.E.3
Aimova, D.4
Eckschlager, T.5
Hrabeta, J.6
Stiborova, M.7
-
16
-
-
63149114184
-
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells
-
J. Poljaková, T. Eckschlager, J. Hraběta, J. Hřebačková, S. Smutný, and E. Frei The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells Biochem Pharmacol 77 2009 1466 1479
-
(2009)
Biochem Pharmacol
, vol.77
, pp. 1466-1479
-
-
Poljaková, J.1
Eckschlager, T.2
Hraběta, J.3
Hřebač ková, J.4
Smutný, S.5
Frei, E.6
-
17
-
-
77349123536
-
Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells
-
E. Martínková, M. Dontenwill, E. Frei, and M. Stiborová Cytotoxicity of and DNA adduct formation by ellipticine in human U87MG glioblastoma cancer cells Neuro Endocrinol Lett 30 Suppl. 1 2009 60 66
-
(2009)
Neuro Endocrinol Lett
, vol.30
, Issue.SUPPL. 1
, pp. 60-66
-
-
Martínková, E.1
Dontenwill, M.2
Frei, E.3
Stiborová, M.4
-
18
-
-
34047199261
-
Cytohromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes
-
V. Kotrbová, D. Aimová, A. Březinová, K. Janouchová, J. Poljaková, and P. Hodek Cytochromes P450 reconstituted with NADPH:P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes Neuro Endocrinol Lett 27 Suppl. 2 2006 18 20 (Pubitemid 46534329)
-
(2006)
Neuroendocrinology Letters
, vol.27
, Issue.SUPPL. 2
, pp. 18-20
-
-
Kotrbova, V.1
Aimova, D.2
Brezinova, A.3
Janouchova, K.4
Poljakova, J.5
Hodek, P.6
Frei, E.7
Stiborova, M.8
-
23
-
-
0024289285
-
Investigation of the bicinchoninic acid protein assay: Identification of the groups responsible for color formation
-
K.J. Wiechelman, R.D. Braun, and J.D. Fitzpatrick Investigation of the bicinchoninic acid protein assay: identification of the groups responsible for color formation Anal Biochem 175 1988 231 237
-
(1988)
Anal Biochem
, vol.175
, pp. 231-237
-
-
Wiechelman, K.J.1
Braun, R.D.2
Fitzpatrick, J.D.3
-
24
-
-
0037108678
-
Sudan I is a potential carcinogen for humans: Evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes
-
M. Stiborová, V. Martínek, H. Rýdlová, P. Hodek, and E. Frei Sudan I is a potential carcinogen for humans: evidence for its metabolic activation and detoxication by human recombinant cytochrome P450 1A1 and liver microsomes Cancer Res 62 2002 5678 5684 (Pubitemid 35204721)
-
(2002)
Cancer Research
, vol.62
, Issue.20
, pp. 5678-5684
-
-
Stiborova, M.1
Martinek, V.2
Rydlova, H.3
Hodek, P.4
Frei, E.5
-
25
-
-
0017057951
-
Properties of electrophoretically homogeneous phenobarbital inducible and β naphthoflavone inducible forms of liver microsomal cytochrome P 450
-
D.A. Haugen, and M.J. Coon Properties of electrophoretically homogeneous phenobarbital-inducible and beta-naphthoflavone-inducible forms of liver microsomal cytochrome P-450 J Biol Chem 251 1976 7929 7939 (Pubitemid 8015807)
-
(1976)
Journal of Biological Chemistry
, vol.251
, Issue.24
, pp. 7929-7939
-
-
Haugen, D.A.1
Coon, M.J.2
-
26
-
-
0017326501
-
NADPH cytochrome P 450 reductase from rat liver: purification by affinity chromatography and characterization
-
J.D. Dignam, and H.W. Strobel NADPH-cytochrome P-450 reductase from rat liver: purification by affinity chromatography and characterization Biochemistry 6 1977 1116 1123 (Pubitemid 8062247)
-
(1977)
Biochemistry
, vol.16
, Issue.6
, pp. 1116-1123
-
-
Dignam, J.D.1
Strobel, H.W.2
-
30
-
-
41949131364
-
5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4
-
5 inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P450 2B4 J Biol Chem 283 2008 5217 5225
-
(2008)
J Biol Chem
, vol.283
, pp. 5217-5225
-
-
Zhang, H.1
Hamdane, D.2
Im, S.C.3
Waskell, L.4
-
31
-
-
0000280194
-
The isolation and properties of microsomal cytochrome
-
P. Strittmatter, and S.F. Velick The isolation and properties of microsomal cytochrome J Biol Chem 221 1956 253 264
-
(1956)
J Biol Chem
, vol.221
, pp. 253-264
-
-
Strittmatter, P.1
Velick, S.F.2
-
32
-
-
0017869007
-
The measurement of difference spectra: Application to the cytochromes of microsomes
-
R.W. Estabrook, and J. Werringloer The measurement of difference spectra: application to the cytochromes of microsomes Methods Enzymol 52 1978 212 220
-
(1978)
Methods Enzymol
, vol.52
, pp. 212-220
-
-
Estabrook, R.W.1
Werringloer, J.2
-
34
-
-
17644405812
-
Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers
-
DOI 10.1016/j.canlet.2004.07.036
-
M. Stiborová, V. Martínek, H. Rýdlová, T. Koblas, and P. Hodek Expression of cytochrome P450 1A1 and its contribution to oxidation of a potential human carcinogen 1-phenylazo-2-naphthol (Sudan I) in human livers Cancer Lett 220 2005 145 154 (Pubitemid 40568771)
-
(2005)
Cancer Letters
, vol.220
, Issue.2
, pp. 145-154
-
-
Stiborova, M.1
Martinek, V.2
Rydlova, H.3
Koblas, T.4
Hodek, P.5
-
35
-
-
78649874077
-
Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4
-
Y. Farooq, and G.C.K. Gordon Kinetics of electron transfer between NADPH-cytochrome P450 reductase and cytochrome P450 3A4 Biochem J 432 2010 485 493
-
(2010)
Biochem J
, vol.432
, pp. 485-493
-
-
Farooq, Y.1
Gordon, G.C.K.2
-
36
-
-
34748888569
-
The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism
-
DOI 10.1124/dmd.107.016048
-
D. Aimová, L. Svobodová, V. Kotrbová, B. Mrazová, P. Hodek, and J. Hudeček The anticancer drug ellipticine is a potent inducer of rat cytochromes P450 1A1 and 1A2, thereby modulating its own metabolism Drug Metab Dispos 35 2007 1926 1934 (Pubitemid 47481588)
-
(2007)
Drug Metabolism and Disposition
, vol.35
, Issue.10
, pp. 1926-1934
-
-
Aimova, D.1
Svobodova, L.2
Kotrbova, V.3
Mrazova, B.4
Hodek, P.5
Hudecek, J.6
Vaclavikova, R.7
Frei, E.8
Stiborova, M.9
-
37
-
-
33845240192
-
Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - Similarity between human and rat systems
-
M. Stiborová, L. Bořek-Dohalská, D. Aimová, V. Kotrbová, K. Kukacková, and K. Janouchová Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems Gen Physiol Biophys 25 2006 245 261 (Pubitemid 44857439)
-
(2006)
General Physiology and Biophysics
, vol.25
, Issue.3
, pp. 245-261
-
-
Stiborova, M.1
Borek-Dohalska, L.2
Aimova, D.3
Kotrbova, V.4
Kukackova, K.5
Janouchova, K.6
Rupertova, M.7
Ryslava, H.8
Hudecek, J.9
Frei, E.10
-
38
-
-
0025992864
-
Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes
-
F.P. Guengerich, and T. Shimada Oxidation of toxic and carcinogenic chemicals by human cytochrome P450 enzymes Chem Res Toxicol 4 1991 391 407
-
(1991)
Chem Res Toxicol
, vol.4
, pp. 391-407
-
-
Guengerich, F.P.1
Shimada, T.2
-
39
-
-
0030834058
-
Human cytochrome P450 enzymes: A status report summarizing their reactions, substrates, inducers, and inhibitors
-
S. Rendic, and F.J. DiCarlo Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors Drug Metab Rev 29 1997 413 480
-
(1997)
Drug Metab Rev
, vol.29
, pp. 413-480
-
-
Rendic, S.1
Dicarlo, F.J.2
-
42
-
-
0037099292
-
Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes
-
DOI 10.1016/S0006-2952(02)01072-9, PII S0006295202010729
-
E. Frei, C.A. Bieler, V.M. Arlt, M. Wiessler, and M. Stiborová Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes Biochem Pharmacol 64 2002 289 295 (Pubitemid 34775308)
-
(2002)
Biochemical Pharmacology
, vol.64
, Issue.2
, pp. 289-295
-
-
Frei, E.1
Bieler, C.A.2
Arlt, V.M.3
Wiessler, M.4
Stiborova, M.5
-
43
-
-
57149128596
-
Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA
-
M. Moserová, V. Kotrbová, M. Rupertová, K. Naiman, J. Hudeček, and P. Hodek Isolation and partial characterization of the adduct formed by 13-hydroxyellipticine with deoxyguanosine in DNA Neuro Endocrinol Lett 29 2008 728 732
-
(2008)
Neuro Endocrinol Lett
, vol.29
, pp. 728-732
-
-
Moserová, M.1
Kotrbová, V.2
Rupertová, M.3
Naiman, K.4
Hudeček, J.5
Hodek, P.6
-
44
-
-
35648963202
-
5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4
-
DOI 10.1074/jbc.M703845200
-
5 increases the rate of product formation by cytochrome P450 2B4 and competes with cytochrome P450 reductase for a binding site on cytochrome P450 2B4 J Biol Chem 282 2007 29766 29776 (Pubitemid 350035259)
-
(2007)
Journal of Biological Chemistry
, vol.282
, Issue.41
, pp. 29766-29776
-
-
Zhang, H.1
Im, S.-C.2
Waskell, L.3
-
45
-
-
0030582844
-
Analysis of structural requirements for Ah receptor antagonist activity: Ellipticines, flavones, and related compounds
-
T.A. Gasiewicz, R.S. Kende, G. Rucci, B. Whitney, and J.J. Willey Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds Biochem Pharmacol 52 1996 787 830
-
(1996)
Biochem Pharmacol
, vol.52
, pp. 787-830
-
-
Gasiewicz, T.A.1
Kende, R.S.2
Rucci, G.3
Whitney, B.4
Willey, J.J.5
-
46
-
-
79952796704
-
Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: Additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney
-
M. Stiborová, M. Moserová, B. Mrázová, V. Kotrbová, and E. Frei Role of cytochromes P450 and peroxidases in metabolism of the anticancer drug ellipticine: additional evidence of their contribution to ellipticine activation in rat liver, lung and kidney Neuro Endocrinol Lett 31 Suppl. 2 2010 26 35
-
(2010)
Neuro Endocrinol Lett
, vol.31
, Issue.SUPPL. 2
, pp. 26-35
-
-
Stiborová, M.1
Moserová, M.2
Mrázová, B.3
Kotrbová, V.4
Frei, E.5
-
49
-
-
0030686551
-
Environment and cancer: Who are susceptible?
-
DOI 10.1126/science.278.5340.1068
-
F.P. Perera Environment and cancer: who are susceptible? Science 278 1997 1068 1073 (Pubitemid 27517877)
-
(1997)
Science
, vol.278
, Issue.5340
, pp. 1068-1073
-
-
Perera, F.P.1
-
50
-
-
0036401287
-
Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung
-
J. Hukkanen, O. Pelkonen, J. Hakkola, and H. Raunio Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung Crit Rev Toxicol 32 2002 391 411 (Pubitemid 35191358)
-
(2002)
Critical Reviews in Toxicology
, vol.32
, Issue.5
, pp. 391-411
-
-
Hukkanen, J.1
Pelkonen, O.2
Hakkola, J.3
Raunio, H.4
-
51
-
-
10644271665
-
Induction of cytochromes P450
-
DOI 10.2174/1568026043387115
-
M. Dickins Induction of cytochromes P450 Curr Top Med Chem 4 2004 1745 1766 (Pubitemid 39654460)
-
(2004)
Current Topics in Medicinal Chemistry
, vol.4
, Issue.16
, pp. 1745-1766
-
-
Dickins, M.1
-
52
-
-
33745612955
-
Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans
-
S.Y. Bae, S.K. Choi, K.R. Kim, C.S. Park, S.K. Lee, and H.K. Roh Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans Cancer Sci 97 2006 774 779
-
(2006)
Cancer Sci
, vol.97
, pp. 774-779
-
-
Bae, S.Y.1
Choi, S.K.2
Kim, K.R.3
Park, C.S.4
Lee, S.K.5
Roh, H.K.6
-
53
-
-
44449086554
-
Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking
-
K. Yoshida, K. Osawa, M. Kasahara, A. Miyaishi, K. Nakanishi, and S. Hayamizu Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking Asian Pac J Cancer Prev 8 2007 438 444
-
(2007)
Asian Pac J Cancer Prev
, vol.8
, pp. 438-444
-
-
Yoshida, K.1
Osawa, K.2
Kasahara, M.3
Miyaishi, A.4
Nakanishi, K.5
Hayamizu, S.6
-
54
-
-
3042525107
-
Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia
-
A. D'Alo, M. Voso, F. Guidy, G. Kaseiny, S. Sica, and L. Pagano Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukaemia Haematologica 89 2004 664 670 (Pubitemid 38828472)
-
(2004)
Haematologica
, vol.89
, Issue.6
, pp. 664-670
-
-
D'Alo, F.1
Voso, M.T.2
Guidi, F.3
Massini, G.4
Scardocci, A.5
Sica, S.6
Pagano, L.7
Hohaus, S.8
Leone, G.9
-
55
-
-
18944400490
-
Phase I/II enzyme gene polymorphisms and esophageal cancer risk: A meta-analysis of the literature
-
C.X. Yang, K. Matsuo, Z. Wang, and K. Tajima Phase I/II enzyme gene polymorphisms and esophageal cancer risk: a meta-analysis of the literature World J Gastroenterol 11 2005 2534 2538
-
(2005)
World J Gastroenterol
, vol.11
, pp. 2534-2538
-
-
Yang, C.X.1
Matsuo, K.2
Wang, Z.3
Tajima, K.4
-
56
-
-
7044227917
-
Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer among African-American and white women
-
Y. Li, R. Millikan, D. Bell, L. Cui, C. Tse, and B. Newman Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer among African-American and white women Breast Cancer Res 6 2004 R460 R473
-
(2004)
Breast Cancer Res
, vol.6
-
-
Li, Y.1
Millikan, R.2
Bell, D.3
Cui, L.4
Tse, C.5
Newman, B.6
-
57
-
-
33644783045
-
Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: A population-based case-control study
-
Y. Li, R. Millikan, D. Bell, L. Cui, C. Tse, and B. Newman Polychlorinated biphenyls, cytochrome P450 1A1 (CYP1A1) polymorphisms, and breast cancer risk among African American women and white women in North Carolina: a population-based case-control study Breast Cancer Res 7 2005 R12 R18
-
(2005)
Breast Cancer Res
, vol.7
-
-
Li, Y.1
Millikan, R.2
Bell, D.3
Cui, L.4
Tse, C.5
Newman, B.6
-
58
-
-
0032929010
-
Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans
-
M. Nakajima, T. Yokoi, M. Mizutani, M. Kinoshita, M. Funayama, and T. Kamataki Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans J Biochem 125 1999 803 808 (Pubitemid 29192503)
-
(1999)
Journal of Biochemistry
, vol.125
, Issue.4
, pp. 803-808
-
-
Nakajima, M.1
Yokoi, T.2
Mizutani, M.3
Kinoshita, M.4
Funayama, M.5
Kamataki, T.6
-
59
-
-
0032908778
-
Functional significance of a C→A polymorphism in intron I of the cytochrome P450 CYP1A2 gene tested with caffeine
-
DOI 10.1046/j.1365-2125.1999.00898.x
-
C. Sachse, J. Brockmoller, S. Bauer, and I. Roots Functional significance of a C → A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine Br J Clin Pharmacol 47 1999 445 449 (Pubitemid 29161279)
-
(1999)
British Journal of Clinical Pharmacology
, vol.47
, Issue.4
, pp. 445-449
-
-
Sachse, C.1
Brockmoller, J.2
Bauer, S.3
Roots, I.4
-
60
-
-
34247609838
-
Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans
-
DOI 10.1007/s00228-007-0288-2
-
R. Ghotbi, M. Christensen, H.K. Roh, M. Ingelman-Sundberg, E. Aklillu, and L. Bertilsson Comparisons of CYP1A2 genetic polymorphisms, enzyme activity and the genotype-phenotype relationship in Swedes and Koreans Eur J Clin Pharmacol 63 2007 537 546 (Pubitemid 46684487)
-
(2007)
European Journal of Clinical Pharmacology
, vol.63
, Issue.6
, pp. 537-546
-
-
Ghotbi, R.1
Christensen, M.2
Roh, H.-K.3
Ingelman-Sundberg, M.4
Aklillu, E.5
Bertilsson, L.6
-
61
-
-
0036433001
-
Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2
-
DOI 10.1046/j.1365-2125.2002.01686.x
-
X.M. Han, D.S. Ouyang, X.P. Chen, Y. Shu, C.H. Jiang, and Z.R. Tan Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2 Br J Clin Pharmacol 54 2002 540 543 (Pubitemid 35356882)
-
(2002)
British Journal of Clinical Pharmacology
, vol.54
, Issue.5
, pp. 540-543
-
-
Han, X.-M.1
Ouyang, D.-S.2
Chen, X.-P.3
Shu, Y.4
Jiang, C.-H.5
Tan, Z.-R.6
Zhou, H.-H.7
-
62
-
-
36148976077
-
Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects
-
DOI 10.1016/j.pharmthera.2007.09.004, PII S016372580700201X
-
M. Ingelman-Sundberg, S.C. Sim, A. Gomez, and C. Rodriguez-Antona Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol Ther 116 2007 496 526 (Pubitemid 350116943)
-
(2007)
Pharmacology and Therapeutics
, vol.116
, Issue.3
, pp. 496-526
-
-
Ingelman-Sundberg, M.1
Sim, S.C.2
Gomez, A.3
Rodriguez-Antona, C.4
-
63
-
-
0033632228
-
CP3A4 allelic variants with amino acid substitutions in exons 7 and 12: Evidence for an allelic variant with altered catalytic activity
-
F. Sata, A. Sapone, G. Elizondo, P. Stocker, V.P. Miller, and W. Zheng CYP3A4 allelic variants with amino acid substitutions in exons 7 and 12: evidence for an allelic variant with altered catalytic activity Clin Pharmacol Ther 67 2000 48 56 (Pubitemid 30078387)
-
(2000)
Clinical Pharmacology and Therapeutics
, vol.67
, Issue.1
, pp. 48-56
-
-
Sata, F.1
Sapone, A.2
Elizondo, G.3
Stocker, P.4
Miller, V.P.5
Zheng, W.6
Raunio, H.7
Crespi, C.L.8
Gonzalez, F.J.9
-
64
-
-
34248597547
-
Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes
-
DOI 10.2217/14622416.8.5.443
-
M. Schirmer, A. Rosenberger, K. Klein, B. Kulle, M.R. Toliat, and P. Nurnberg Sex-dependent genetic markers of CYP3A4 expression and activity in human liver microsomes Pharmacogenomics 8 2007 443 453 (Pubitemid 46746352)
-
(2007)
Pharmacogenomics
, vol.8
, Issue.5
, pp. 443-453
-
-
Schirmer, M.1
Rosenberger, A.2
Klein, K.3
Kulle, B.4
Toliat, M.R.5
Nurnberg, P.6
Zanger, U.M.7
Wojnowski, L.8
-
65
-
-
54949144309
-
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation
-
U.M. Zanger, M. Turpeinen, K. Klein, and M. Schwab Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation Anal Bioanal Chem 392 2008 1093 1108
-
(2008)
Anal Bioanal Chem
, vol.392
, pp. 1093-1108
-
-
Zanger, U.M.1
Turpeinen, M.2
Klein, K.3
Schwab, M.4
|